FDA grants bioMérieux dual clearance and CLIA waiver for the BIOFIRE SPOTFIRE Vaginitis Panel, a rapid 20-minute ...
Hologic and Inpeco have partnered to connect Panther Systems with FlexLab X automation in Europe, aiming to improve ...
Quest Diagnostics and Waters will expand at-home HPV screening in 2027, offering extended genotyping via the Onclarity ...
A study reports that liquid biopsy tests can detect early lung cancer recurrence months before imaging in NSCLC patients.
Illumina has introduced three early-access software capabilities on its BioInsight Platform designed to automate informatics ...
A study finds permissive lab screening thresholds double primary aldosteronism detection rates versus Endocrine Society ...
Biodesix, in partnership with Bio-Rad and Thermo Fisher Scientific, advances tumor-informed and tumor-naïve MRD assays for ...
Gene by Gene will provide whole-genome sequencing for Children’s Mercy’s program, targeting nearly 100,000 pediatric genomes.
Guardant Health and partners will present 25 abstracts on liquid biopsy advances for cancer monitoring at ESMO 2026.
WHO grants Emergency Use Listing to BioFire’s Global Fever Special Pathogens Panel, enabling rapid detection of Ebola and 15 ...
Ultima Genomics’ UG200 Platform will support an 80,000-sample UK Biobank immune profiling study with IMU Biosciences.
Biodesix Partners With Vanderbilt to Develop Lung Cancer Risk Test Combining Blood Tests and Imaging
Biodesix and Vanderbilt are developing an AI-driven lung cancer risk test combining blood-based and imaging biomarkers.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results